title: Posterior reversible encephalopathy syndrome after high-dose cytarabine in acute myelogenous leukemia.
authors.affiliation: Department of Neurology, University of Missouri-Columbia, Columbia, Missouri, USA.
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Newey
authors.affiliation: Department of Neurology, University of Missouri-Columbia, Columbia, Missouri, USA.
authors.forename: Premkumar N
authors.initials: PN
authors.lastname: Chandrasekaran
authors.affiliation: Department of Emergency Medicine, University of Missouri-Columbia, Columbia, Missouri, USA.
authors.forename: Mohammad R
authors.initials: MR
authors.lastname: Mohebbi
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000000981:diagnostic imaging*
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine